Impact of Glycemic Control on Penile Duplex Results
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexMale
Age30-55
SponsorAssiut University
About this trial
The study aimed at evaluating the impact of glycemic control on the erectile function , penile Doppler, and cavernosal blood NO and glutathione levels among a group of diabetic patients with erectile dysfunction.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Married Male patients diagnosed with erectile dysfunction.
Age from 30 to 55 years.
Documented history of DM.
Regular sexual life with cooperative wife.
Disqualifiers
Patients with congenital anomalies like hypospadius and curvature.
History of pelvic or spine surgery.
Single patient.
Other sexual disorders.
Trial population
This prospective observational study will include 100 patients attending our andrology outpatient clinic at Assuit University Hospitals, Egypt, complaining of uncontrolled diabetes mellitus (HBA1C more than 8) and secondary ED for more than 6 months, from October 2023 and over a year. Patients will be included in the study after obtaining a written informed consent and ethical committee approval.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Penile doppler ultrasound
penile Doppler and measuring cavernosal blood nitric oxide and glutathione levels to compare penile doppler ultrasound brfore and after glycemic control .
Time frame
Baseline2
Cavernosal blood nitric oxide
Comparing cavernosal blood nitric oxide brfore and after glycemic control
Time frame
Baseline3
Cavernosal blood glutathione level
Comparing cavernosal blood glutathione levels brfore and after glycemic control
Time frame
BaselineLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: